NASDAQ:ADIL | Profit Breakdown | ADIAL PHARMACEUTICALS, INC.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$52.03M-$51.99M
2026-03-31-$2M-$2.02M
2025-12-31-$1.89M-$2M
2025-09-30-$1.76M-$1.79M
2025-06-30-$1.88M-$1.96M
2025-03-31-$2.27M-$2.23M
2024-12-31-$1.94M-$2.07M-$2.07M
2024-09-30-$2.21M-$2.19M-$2.19M
2024-06-30-$2.29M-$2.46M-$2.46M
2024-03-31-$1.85M-$6.48M
2023-12-31-$1.78M-$1.9M-$1.92M
2023-09-30-$1.36M-$1.35M-$1.38M
2023-06-30-$1.48M-$1.51M$1.09M
2023-03-31-$2.92M-$2.91M-$2.91M
2022-12-31-$2.6M-$2.55M-$2.87M
2022-09-30-$2.55M-$2.55M-$3.11M
2022-06-30-$3.24M-$3.24M-$3.85M
2022-03-31-$3.06M-$2.91M-$2.91M
2021-12-31-$5.98M-$5.92M-$5.83M
2021-09-30-$4.06M-$4.32M-$4.32M
2021-06-30-$4.4M-$4.44M-$4.44M
2021-03-31-$4.84M-$4.83M-$4.83M
2020-12-31-$3.47M-$3.47M-$3.47M
2020-09-30-$3.34M-$3.34M-$3.34M
2020-06-30-$1.82M-$1.81M-$1.81M
2020-03-31-$2.3M-$2.28M-$2.28M
2019-12-31-$2.09M-$2.06M-$2.06M
2019-09-30-$1.75M-$1.72M-$1.72M
2019-06-30-$2.16M-$2.13M-$2.13M
2019-03-31-$2.25M-$2.68M-$2.68M
2018-12-31-$1.09M-$1.27M-$1.27M
2018-09-30-$3.82M-$8.19M-$8.19M
2018-06-30-$1.74M-$1.79M-$1.79M
2018-03-31-$339,513.00-$378,950.00-$378,950.00
2017-12-31-$321,794.00-$403,992.00-$403,992.00
2017-09-30-$262,416.00-$292,626.00-$292,626.00
2017-06-30-$241,485.00-$264,273.00-$264,273.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$7.8M-$7.98M-$7.98M
2024-12-31-$8.28M-$13.2M-$13.2M
2023-12-31-$6.89M-$7M-$5.12M
2022-12-31-$10.86M-$10.8M-$12.73M
2021-12-31-$19.29M-$19.52M-$19.42M
2020-12-31-$10.93M-$10.89M-$10.89M
2019-12-31-$8.24M-$8.59M-$8.59M
2018-12-31-$6.99M-$11.63M-$11.63M
2017-12-31-$995,286.00-$1.14M-$1.14M